SEC 13F Intelligence

Krensavage Asset Management, LLC / JAZZ

Krensavage Asset Management, LLC’s Jazz Pharmaceuticals PLC Position

Does Krensavage Asset Management, LLC own Jazz Pharmaceuticals PLC (JAZZ)? Yes — 167.8K shares worth $32M (+12.41% of its 13F portfolio) as of Q1 2026.

Position Value
$32M
Q1 2026
Shares
167.8K
% of Portfolio
+12.41%
Quarters Held
10
currently held

Position History JAZZ

Reported value by quarter
Q4 ’23: $12MQ4 ’23Q1 ’24: $12MQ2 ’24: $12MQ2 ’24Q3 ’24: $12MQ4 ’24: $13MQ4 ’24Q1 ’25: $13MQ2 ’25: $17MQ2 ’25Q3 ’25: $22MQ4 ’25: $29MQ4 ’25Q1 ’26: $32Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026167.8K$32M+12.41%
Q4 2025167.8K$29M+10.08%
Q3 2025167.8K$22M+9.42%
Q2 2025164.8K$17M+9.26%
Q1 2025100.7K$13M+6.91%
Q4 2024105.8K$13M+7.71%
Q3 2024110.3K$12M+6.88%
Q2 2024109.1K$12M+5.35%
Q1 2024101.2K$12M+5.40%
Q4 2023100.0K$12M+4.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Krensavage Asset Management, LLC’s full portfolio or all institutional holders of JAZZ.